VD

Active Director Designated Partner DIN 09391020
DIN 09391020 First appointment Nov 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Vani Depa

Data last updated:

Vani Depa is a Designated Partner at Sanyug Drugs Llp (since 2021). The company operates in Pharma.

DIN 09391020
Primary Designation Designated Partner
Industry Pharma
First Appointment 09 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sanyug Drugs Llp AAZ-4000
Designated Partner09 Nov 20212021Active

Board colleagues of Vani Depa

NameDINCompanyDesignation
Aditi Amit Khandagale09391021Sanyug Drugs LlpDesignated Partner
Mareddy Srimannarayan Reddy02404734Sanyug Drugs LlpDesignated Partner
Santhosh Kumar Reddy Bollepally09373343Sanyug Drugs LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Sanyug Drugs Llp
Premium access

Shareholding and investment profile for Vani Depa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vani Depa

Vani Depa currently holds 1 directorship: Sanyug Drugs Llp (Designated Partner, since 09 Nov 2021).

Vani Depa was first appointed on 09 Nov 2021 as Designated Partner at Sanyug Drugs Llp.

The current boards of Vani Depa's companies include Aditi Amit Khandagale (Sanyug Drugs Llp), Mareddy Srimannarayan Reddy (Sanyug Drugs Llp), Santhosh Kumar Reddy Bollepally (Sanyug Drugs Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available